SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20233183
Source:
http://linkedlifedata.com/resource/pubmed/id/20233183
Search
Subject
(
86
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0021467
,
umls-concept:C0021469
,
umls-concept:C0028426
,
umls-concept:C0205210
,
umls-concept:C0205976
,
umls-concept:C1176140
,
umls-concept:C1332829
,
umls-concept:C1704675
,
umls-concept:C2674784
pubmed:issue
2
pubmed:dateCreated
2010-3-17
pubmed:abstractText
To investigate the inhibition potential and kinetic information of noscapine to seven CYP isoforms and extrapolate in vivo noscapine-warfarin interaction magnitude from in vitro data.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/DA 012521
,
http://linkedlifedata.com/resource/pubmed/grant/P30 DA012393
,
http://linkedlifedata.com/resource/pubmed/grant/P50 DA018179
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-10497145
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-11467081
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-12146628
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-12433825
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-14209971
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-14907713
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-15280511
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-15297423
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-16236041
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-16645869
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-16985100
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-17093004
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-17440101
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-17875192
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-18303135
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-18474676
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-19350451
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-2257866
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-4896713
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-527635
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-9014207
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233183-9465062
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7503323
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants
,
http://linkedlifedata.com/resource/pubmed/chemical/Antitussive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases
,
http://linkedlifedata.com/resource/pubmed/chemical/CYP2C9 protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/CYP3A4 protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP3A
,
http://linkedlifedata.com/resource/pubmed/chemical/Noscapine
,
http://linkedlifedata.com/resource/pubmed/chemical/Warfarin
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1365-2125
pubmed:author
pubmed-author:FangZhong-ZeZZ
,
pubmed-author:GeGuang-BoGB
,
pubmed-author:HuoHongH
,
pubmed-author:LiangSi-ChengSC
,
pubmed-author:YangLingL
,
pubmed-author:ZhangYan-YanYY
pubmed:issnType
Electronic
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
193-9
pubmed:dateRevised
2011-7-22
pubmed:meshHeading
pubmed-meshheading:20233183-Adult
,
pubmed-meshheading:20233183-Anticoagulants
,
pubmed-meshheading:20233183-Antitussive Agents
,
pubmed-meshheading:20233183-Aryl Hydrocarbon Hydroxylases
,
pubmed-meshheading:20233183-Cytochrome P-450 CYP3A
,
pubmed-meshheading:20233183-Dose-Response Relationship, Drug
,
pubmed-meshheading:20233183-Drug Interactions
,
pubmed-meshheading:20233183-Humans
,
pubmed-meshheading:20233183-Male
,
pubmed-meshheading:20233183-Microsomes, Liver
,
pubmed-meshheading:20233183-Middle Aged
,
pubmed-meshheading:20233183-Models, Biological
,
pubmed-meshheading:20233183-Models, Chemical
,
pubmed-meshheading:20233183-Noscapine
,
pubmed-meshheading:20233183-Time Factors
,
pubmed-meshheading:20233183-Tissue Culture Techniques
,
pubmed-meshheading:20233183-Warfarin
pubmed:year
2010
pubmed:articleTitle
Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction.
pubmed:affiliation
Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.
pubmed:publicationType
Journal Article
,
Research Support, N.I.H., Extramural